This paper is in the following e-collection/theme issue:

Public Health Informatics (92) Prevention and Health Promotion (983) Cross-Sectional Studies in Public Health (276)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45747, first published .
Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Authors of this article:

Limin Wang1, 2, 3 Author Orcid Image ;   Shimeng Liu4, 5 Author Orcid Image ;   Shan Jiang6 Author Orcid Image ;   Chaofan Li1, 2, 3 Author Orcid Image ;   Liyong Lu1, 2, 3 Author Orcid Image ;   Yunhai Fang7 Author Orcid Image ;   Shunping Li1, 2, 3 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Journals

  1. Huang K. The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies. JMIR Public Health and Surveillance 2024;10:e51372 View
  2. Wang L, Liu S, Jiang S, Li C, Lu L, Fang Y, Li S. Authors’ Reply: “The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies”. JMIR Public Health and Surveillance 2024;10:e54756 View